News

AbbVie ABBV continues to build momentum with its oncology franchise, with the recent FDA approval for Emrelis. This ...
Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.
GoodRx tracked how inflation is hitting consumers across different budget categories, including prescription medications.
While your morning brew might feel harmless, it can interact with certain medicines to reduce effectiveness or increase side ...
He spotted the opportunity to invest in weight-loss drugs in 2023 before they exploded in 2024, and was an early AI mover, which he spied as a game changer in late 2022, early 2023. It's all about ...
Zacks Investment Research on MSN2dOpinion
New Strong Buy Stocks for June 4th
List today: BioCryst Pharmaceuticals BCRX: This company which is a leader in the use of crystallography and structure-based ...
The summary below gives an overview of important additions and changes MPR has made to its drug database through the end of May 2025. The chart below provides highlights of key monograph updates made ...
After your RV gets blown sky-high in a hit, you're broke, stranded and hiding out in a rundown motel with a growing list of enemies ... game about building a drug empire from the ground up ...
Last week, the FDA officially moved Ozempic and Wegovy off its shortage list four months after the drug was found to available in the U.S. During the time that semaglutide has been on the list ...
Background Patients often carry medication lists to mitigate information loss across healthcare settings. We aimed to identify mechanisms by which these lists could be used to support safety, key ...
Different methods employ different definitions. Chart-review studies define medication errors as errors in the ordering, transcribing, dispensing, administering, or monitoring of a medication.
The idea was borrowed partly from large pharmacy chains such as Walmart, which offers customers a straightforward $4 drug list. “A standardized list with consistent cost-sharing would allow ...